Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Haak

Showing results (111-120 of 184) with videos related to

Pageof 19
Sort By:
Plos One|June 1, 2026
Introducing the Dutch Quality Registry for Acute Internal Medicine (DRAIM): Method of development and opportunities of use from a single-centre pilot studyMarleen G A M van der Velde, Elisabeth M Mols, Jelmer Alsma, et al.
Journal of Comorbidity|November 2, 2017
Diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancerMaren A van Waalwijk, Saskia A M van de Schans, Harm R Haak, et al.
BMJ Open|December 29, 2017
Association of socioeconomic status with outcomes in older adult community-dwelling patients after visiting the emergency department: a retrospective cohort studyJoyce J H Wachelder, Isabelle van Drunen, Patricia M Stassen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2020
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upM Fassnacht, G Assie, E Baudin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2022
Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]M Fassnacht, G Assie, E Baudin, et al.
Clinical Endocrinology|April 6, 2006
Comorbidity in newly diagnosed thyroid cancer patients: a population-based study on prevalence and the impact on treatment and survivalJohannes L P Kuijpens, Maryska L G Janssen-Heijnen, Valery E P P Lemmens, et al.
Journal of Diabetes Science and Technology|December 21, 2014
A physiology-based model describing heterogeneity in glucose metabolism: the core of the Eindhoven Diabetes Education Simulator (E-DES)Anne H Maas, Yvonne J W Rozendaal, Carola van Pul, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2013
Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinomaT M Kerkhofs, E Baudin, M Terzolo, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 2026
Time trends in incidence, treatment and survival of patients with adrenocortical carcinoma, a nationwide studyRebecca V Steenaard, J Sofie de Wit, Marieke Rutjens, et al.
Plos One|December 1, 2017
Elderly emergency patients presenting with non-specific complaints: Characteristics and outcomesJoyce J H Wachelder, Patricia M Stassen, Laura P A M Hubens, et al.
Pageof 19

Showing results (111-120 of 184) with videos related to

Sort By:
Pageof 19
Plos One|June 1, 2026
Introducing the Dutch Quality Registry for Acute Internal Medicine (DRAIM): Method of development and opportunities of use from a single-centre pilot studyMarleen G A M van der Velde, Elisabeth M Mols, Jelmer Alsma, et al.
Journal of Comorbidity|November 2, 2017
Diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancerMaren A van Waalwijk, Saskia A M van de Schans, Harm R Haak, et al.
BMJ Open|December 29, 2017
Association of socioeconomic status with outcomes in older adult community-dwelling patients after visiting the emergency department: a retrospective cohort studyJoyce J H Wachelder, Isabelle van Drunen, Patricia M Stassen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2020
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upM Fassnacht, G Assie, E Baudin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2022
Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]M Fassnacht, G Assie, E Baudin, et al.
Clinical Endocrinology|April 6, 2006
Comorbidity in newly diagnosed thyroid cancer patients: a population-based study on prevalence and the impact on treatment and survivalJohannes L P Kuijpens, Maryska L G Janssen-Heijnen, Valery E P P Lemmens, et al.
Journal of Diabetes Science and Technology|December 21, 2014
A physiology-based model describing heterogeneity in glucose metabolism: the core of the Eindhoven Diabetes Education Simulator (E-DES)Anne H Maas, Yvonne J W Rozendaal, Carola van Pul, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2013
Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinomaT M Kerkhofs, E Baudin, M Terzolo, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 2026
Time trends in incidence, treatment and survival of patients with adrenocortical carcinoma, a nationwide studyRebecca V Steenaard, J Sofie de Wit, Marieke Rutjens, et al.
Plos One|December 1, 2017
Elderly emergency patients presenting with non-specific complaints: Characteristics and outcomesJoyce J H Wachelder, Patricia M Stassen, Laura P A M Hubens, et al.
Pageof 19